VBTX insider sells 10k shares after option exercise at $32.53 avg

Rhea-AI Filing Summary

Form 4 overview: On 07/23/2025 Veritex Holdings (VBTX) Chief Talent Officer Cara McDaniel exercised 10,000 employee stock options at $17.38 (code M) and immediately sold the same 10,000 shares on the open market at a weighted-average $32.5267 (code S; price range $32.52-$32.55).

The option grant, which vested 06/15/2023 and was due to expire 06/15/2030, is now fully settled, leaving McDaniel with zero derivative securities. After the transactions she continues to hold 17,372 common shares directly, the same level as before the exercise-and-sale sequence. The spread between exercise and sale prices implies pre-tax proceeds of roughly $152 k.

No other acquisitions, dispositions, or indirect holdings were reported, and the filing involves a single reporting person.

Insights

Securities Analyst

TL;DR: Routine option exercise and sale; ownership unchanged, limited signalling value.

The filing shows a classic cashless exercise: McDaniel converted in-the-money options, then liquidated the shares, realising a ~87% premium over the strike. She retains 17,372 shares, so her economic exposure remains modest but intact. Given Veritex’s ~US$1 bn market cap, the $0.3 m gross trade is immaterial (<0.03% of equity). Such insider sales can hint at profit-taking but, in isolation, do not alter the investment thesis. No red flags on option timing or pricing are evident.

Insider Trade Summary

Exercise and Sale: 10,000 shares ($151K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider McDANIEL CARA

Role Chief Talent Officer

Sold 10,000 shs ($325K)

Approx. gross sale proceeds $325K

Approx. exercise cost $174K

Approx. pre-tax spread $151K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy)	10,000	$17.38	$174K
Exercise	Common Stock	10,000	$17.38	$174K
Sale	Common Stock	10,000	$32.5267	$325K

Holdings After Transaction: Employee Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 17,372 shares (Direct)

Footnotes (3)

1. F1. Reflects the weighted average sales price for the reported transactions. The shares were sold in multiple transactions at prices ranging from $32.52 to $32.55, inclusive.
2. F2. The grant vest fully on June 15, 2023.
3. F3. The grant expires on June 15, 2030.

FAQ

How many VBTX shares did Cara McDaniel sell on 07/23/2025?

She sold 10,000 common shares.

What price did the insider receive for the VBTX shares?

The weighted-average sale price was $32.5267 (range $32.52-$32.55).

What was the exercise price of the options exercised?

The employee stock options were exercised at $17.38 per share.

How many VBTX shares does McDaniel still own after the transactions?

She directly owns 17,372 common shares.

Does McDaniel have any remaining derivative securities?

No, the Form 4 shows 0 derivative securities remaining.

What is Cara McDaniel’s role at Veritex Holdings?

She is the company’s Chief Talent Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/24/2025 - 07:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

McDANIEL CARA

(Last) (First) (Middle)

C/O VERITEX HOLDINGS, INC

8214 WESTCHESTER DRIVE, SUITE 800

(Street)

DALLAS TX 75225

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Veritex Holdings, Inc. [ VBTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Talent Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/23/2025		M		10,000	A	$17.38	27,372	D
Common Stock	07/23/2025		S		10,000	D	$32.5267(1)	17,372	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$17.38	07/23/2025		M			10,000	(2)	(3)	Common Stock	10,000	$17.38	0	D

Explanation of Responses:

1. Reflects the weighted average sales price for the reported transactions. The shares were sold in multiple transactions at prices ranging from $32.52 to $32.55, inclusive.

2. The grant vest fully on June 15, 2023.

3. The grant expires on June 15, 2030.

Remarks:

	/s/ C. Malcolm Holland, III, by power of attorney	07/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.